Oramed Pharmaceuticals (Israel) Today
| ORMP Stock | 8.50 0.06 0.70% |
Performance0 of 100
| Odds Of DistressOver 68
|
Oramed Pharmaceuticals is trading at 8.50 as of the 26th of November 2024, a 0.7 percent decrease since the beginning of the trading day. The stock's open price was 8.56. Oramed Pharmaceuticals has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Oramed Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2024 and ending today, the 26th of November 2024. Click here to learn more.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. The company has 17.38 M outstanding shares. More on Oramed Pharmaceuticals
Moving against Oramed Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Oramed Pharmaceuticals Risk Profiles
Although Oramed Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Oramed Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.89 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.05 | |||
| Risk Adjusted Performance | (0.02) |
Oramed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Oramed Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Additional Information and Resources on Investing in Oramed Stock
When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.